Immunitor Inc Press Releases - EIN Presswire - Press Release Distribution Service

Published on April 24, 2019 - 10:30 GMT

Immunitor запустил вторую фазу испытаний пероральной иммунотерапевтической вакцины для лечения рака головного мозга

Гонгконг, Гонгконг, April 24, 2019 /⁨EINPresswire.com⁩/ -- Immunitor China Ltd. (Гонконг) заявила о начале испытания иммунотерапевтической вакцины V-Boost на пациентах с наиболее распространенной формой опухоли головного мозга - мультиформной глиобластомой …

Distribution channels: Banking, Finance & Investment Industry, Business & Economy ...

Published on April 23, 2019 - 10:05 GMT

Immunitor initiates Phase II trial of oral immunotherapy vaccine to treat glioblastoma brain cancer

HONG KONG, HONG KONG, April 23, 2019 /⁨EINPresswire.com⁩/ -- Immunitor China Ltd. (Hong Kong) announces launching immunotherapeutic V-Boost vaccine trial in patients with most common form of brain tumor – glioblastoma multiforme (GBM). The open-label Phase …

Distribution channels: Banking, Finance & Investment Industry, Business & Economy ...

Published on November 26, 2018 - 18:05 GMT

Immunitor signs agreement to initiate steps toward clinical development of oral tuberculosis (TB) vaccine in China

HONG KONG, HONG KONG, November 27, 2018 /⁨EINPresswire.com⁩/ -- Immunitor China Ltd. (Hong Kong) announces signing a service agreement with Kun Tuo Medical Research and Development (Beijing) Co., Ltd. - China-based subsidiary of global contract research …

Distribution channels: Banking, Finance & Investment Industry, Business & Economy ...

Published on July 8, 2018 - 23:00 GMT

Immunitor Unveils Five Oral Immunotherapy Vaccines to Treat Women’s Diseases

Immunitor started Phase II clinical trials of tableted vaccines against endometriosis, myoma (uterine fibroids), cervical, ovarian and breast cancers VANCOUVER, BC - BRITISH COLUMBIA, CANADA, July 8, 2018 /⁨EINPresswire.com⁩/ -- Immunitor Inc, recognized …

Distribution channels: Banking, Finance & Investment Industry, Business & Economy ...

Published on April 17, 2017 - 10:13 GMT

Прорывное исследование иммунотерапии при запущенной стадии рака печени

ULAANBAATAR, ULAANBAATAR, MONGOLIA, April 17, 2017 /EINPresswire.com/ -- Улан-Батор, Монголия, 17 апреля 2017 г. - Компания «Иммунитор» опубликовала исследование в области онкоиммунологии, в ходе которого было обнаружено, что гепкортеспенлизимут-L (Гепко- …

Distribution channels: Healthcare & Pharmaceuticals Industry ...